Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Clinical Performance Measures for Neurocritical Care: A Statement for Healthcare Professionals from the Neurocritical Care Society

Abstract

Background

Performance measures are tools to measure the quality of clinical care. To date, there is no organized set of performance measures for neurocritical care.

Methods

The Neurocritical Care Society convened a multidisciplinary writing committee to develop performance measures relevant to neurocritical care delivery in the inpatient setting. A formal methodology was used that included systematic review of the medical literature for 13 major neurocritical care conditions, extraction of high-level recommendations from clinical practice guidelines, and development of a measurement specification form.

Results

A total of 50,257 citations were reviewed of which 150 contained strong recommendations deemed suitable for consideration as neurocritical care performance measures. Twenty-one measures were developed across nine different conditions and two neurocritical care processes of care.

Conclusions

This is the first organized Neurocritical Care Performance Measure Set. Next steps should focus on field testing to refine measure criteria and assess implementation.

This is a preview of subscription content, log in to check access.

Fig. 1
Fig. 2

References

  1. 1.

    Medicine IO. Crossing the quality chasm: a new health system for the 21st Century. Washington (DC): Medicine IO; 2001.

  2. 2.

    Quality AfHRa. 2019. https://www.qualityindicators.ahrq.gov/. Cited in 20 May 2019

  3. 3.

    Moheet AM, Livesay SL, Abdelhak T, et al. Standards for neurologic critical care units: a statement for healthcare professionals from the Neurocritical Care Society. Neurocrit Care. 2018;29(2):145–60.

  4. 4.

    Higgins A, Veselovskiy G, McKown L. Provider performance measures in private and public programs: achieving meaningful alignment with flexibility to innovate. Health Aff (Millwood). 2013;32(8):1453–61.

  5. 5.

    American Academy of Neuorology Stroke and Stroke Rehabiliation Work Group. Quality Measurement Set. 2017. https://www.aan.com/siteassets/home-page/policy-and-guidelines/quality/quality-measures/17iemeasureset_pg.pdf. Cited in 1st Nov 2018.

  6. 6.

    Kotter T, Blozik E, Scherer M. Methods for the guideline-based development of quality indicators–a systematic review. Implement Sci. 2012;7:21.

  7. 7.

    Spertus JA, Eagle KA, Krumholz HM, et al. American College of Cardiology and American Heart Association methodology for the selection and creation of performance measures for quantifying the quality of cardiovascular care. J Am Coll Cardiol. 2005;45(7):1147–56.

  8. 8.

    Stelfox HT, Boyd JM, Straus SE, Gagliardi AR. Developing a patient and family-centred approach for measuring the quality of injury care: a study protocol. BMC Health Serv Res. 2013;13:31.

  9. 9.

    Brouwers MC, Kerkvliet K, Spithoff K, Consortium, A.N.S. The AGREE reporting checklist: a tool to improve reporting of clinical practice guidelines. BMJ. 2016;352:i1152.

  10. 10.

    Guyatt GH, Oxman AD, Vist GE, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336(7650):924–6.

  11. 11.

    Hemphill JC, Greenberg SM, Anderson CS, et al. Guidelines for the management of spontaneous intracerebral hemorrhage: a Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2015;46(7):2032–60.

  12. 12.

    Ahmed N, Steiner T, Caso V, Wahlgren N. Recommendations from the ESO-Karolinska stroke update conference, Stockholm 13–15 November 2016. Eur Stroke J. 2017;2(2):95–102.

  13. 13.

    Albers GW, Amarenco P, Easton JD, Sacco RL, Teal P. Antithrombotic and thrombolytic therapy for ischemic stroke: the seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest. 2004;126(3 Suppl):483S–512S.

  14. 14.

    Albers GW, Amarenco P, Easton JD, Sacco RL, Teal P. Antithrombotic and thrombolytic therapy for ischemic stroke: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition). Chest. 2008;133(6 Suppl):630S–69S.

  15. 15.

    Alonso de Lecinana M, Egido JA, Casado I, et al. Guidelines for the treatment of acute ischaemic stroke. Neurologia. 2014;29(2):102–22.

  16. 16.

    Bernard SA, Gray TW, Buist MD, et al. Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. N Engl J Med. 2002;346(8):557–63.

  17. 17.

    Blackham KA, Meyers PM, Abruzzo TA, et al. Endovascular therapy of acute ischemic stroke: report of the Standards of Practice Committee of the Society of NeuroInterventional Surgery. J Neurointerv Surg. 2012;4(2):87–93.

  18. 18.

    Bonow RO, Bennett S, Casey DE Jr, et al. ACC/AHA clinical performance measures for adults with chronic heart failure: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Heart Failure Clinical Performance Measures) endorsed by the Heart Failure Society of America. J Am Coll Cardiol. 2005;46(6):1144–78.

  19. 19.

    Bonow RO, Bennett S, Casey DE Jr, et al. ACC/AHA clinical performance measures for adults with chronic heart failure: a report of the American College of Cardiology/American Heart Association task force on performance measures (writing committee to develop heart failure clinical performance measures): endorsed by the Heart Failure Society of America. Circulation. 2005;112(12):1853–87.

  20. 20.

    Brophy GM, Bell R, Claassen J, et al. Guidelines for the evaluation and management of status epilepticus. Neurocrit Care. 2012;17(1):3–23.

  21. 21.

    Brouwer MC, McIntyre P, Prasad K, van de Beek D. Corticosteroids for acute bacterial meningitis. Cochrane Database Syst Rev. 2015;9:CD004405.

  22. 22.

    Bryer A, Connor M, Haug P, et al. South African guideline for management of ischaemic stroke and transient ischaemic attack 2010: a guideline from the South African Stroke Society (SASS) and the SASS Writing Committee. S Afr Med J. 2010;100(11 Pt 2):747–78.

  23. 23.

    Callaway CW, Donnino MW, Fink EL, et al. Part 8: post-cardiac arrest care: 2015 American Heart Association guidelines update for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation. 2015;132(18 Suppl 2):S465–82.

  24. 24.

    Cariou A, Payen JF, Asehnoune K, et al. Targeted temperature management in the ICU: guidelines from a French expert panel. Ann Intensive Care. 2017;7(1):70.

  25. 25.

    Carney N, Totten AM, O’Reilly C, et al. Guidelines for the management of severe traumatic brain injury, fourth edition. Neurosurgery. 2017;80(1):6–15.

  26. 26.

    Casaubon LK, Boulanger JM, Blacquiere D, et al. Canadian Stroke best practice recommendations: hyperacute stroke care guidelines, update 2015. Int J Stroke. 2015;10(6):924–40.

  27. 27.

    Castren M, Silfvast T, Rubertsson S, et al. Scandinavian clinical practice guidelines for therapeutic hypothermia and post-resuscitation care after cardiac arrest. Acta Anaesthesiol Scand. 2009;53(3):280–8.

  28. 28.

    Chaudhuri A, Martinez-Martin P, Kennedy PGE, et al. EFNS guideline on the management of community-acquired bacterial meningitis: report of an EFNS Task Force on acute bacterial meningitis in older children and adults. Eur J Neurol. 2008;15(7):649–59.

  29. 29.

    Chevret S, Hughes RA, Annane D. Plasma exchange for Guillain–Barre syndrome. Cochrane Database Syst Rev. 2017;2:CD001798.

  30. 30.

    Christensen AS, Roed C, Omland LH, et al. Long-term mortality in patients with tuberculous meningitis: a Danish nationwide cohort study. PLoS One. 2011;6(11):e27900.

  31. 31.

    Commission, T.J. Acute Stroke ready inpatient set, ASR-IP-1. 2018. https://manual.jointcommission.org/releases/TJC2018A/MIF0350.html. Cited in 1st Nov 2018.

  32. 32.

    Connolly ES, Rabinstein AA, Carhuapoma JR, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2012;43(6):1711–37.

  33. 33.

    Cortese I, Chaudhry V, So YT, et al. Evidence-based guideline update: plasmapheresis in neurologic disorders: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 2011;76(3):294–300.

  34. 34.

    Det Norske Veritas, Comprehensive Stroke Center Certification Program—Requirements. 2012: By request from DNV.

  35. 35.

    Diringer MN, Bleck TP, Hemphill CJ, et al. Critical care management of patients following aneurysmal subarachnoid hemorrhage: recommendations from the Neurocritical Care Society’s Multidisciplinary Consensus Conference. Neurocrit Care. 2011;15(2):211–40.

  36. 36.

    Donnino MW, Andersen LW, Berg KM, et al. Temperature management after cardiac arrest: an advisory statement by the advanced life support task force of the International Liaison Committee on Resuscitation and the American Heart Association Emergency Cardiovascular Care Committee and the Council on cardiopulmonary, critical care, perioperative and resuscitation. Circulation. 2015;132(25):2448–56.

  37. 37.

    DSM Pharmaceuticals, Acyclovir (package insert). Research Triangle Park, NC. 2003. Retrieved September 29, 2019, from https://www.accessdata.fda.gov/drugsatfda_docs/label/2004/18603slr027_zovirax_lbl.pdf.

  38. 38.

    Elovaara I, Apostolski S, van Doorn P, et al. EFNS guidelines for the use of intravenous immunoglobulin in treatment of neurological diseases: eFNS task force on the use of intravenous immunoglobulin in treatment of neurological diseases. Eur J Neurol. 2008;15(9):893–908.

  39. 39.

    European Stroke Organisation Executive, C. Committee, E.S.O.W. Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc Dis. 2008;25(5):457–507.

  40. 40.

    Feasby T, Banwell B, Benstead T, et al. Guidelines on the use of intravenous immune globulin for neurologic conditions. Transfus Med Rev. 2007;21(2 Suppl 1):S57–107.

  41. 41.

    Forum NQ. NQF #0298 Central Line Bundle Compliance. 2012. http://www.qualityforum.org/. Cited in 1st Nov 2018.

  42. 42.

    Fried HI, Nathan BR, Rowe AS, et al. The insertion and management of external ventricular drains: an evidence-based consensus statement: a statement for healthcare professionals from the Neurocritical Care Society. Neurocrit Care. 2016;24(1):61–81.

  43. 43.

    Frontera JA, Lewin JJ, Rabinstein AA, et al. Guideline for reversal of antithrombotics in intracranial hemorrhage: a statement for healthcare professionals from the Neurocritical Care Society and Society of Critical Care Medicine. Neurocrit Care. 2016;24(1):6–46.

  44. 44.

    Glauser T, Shinnar S, Gloss D, et al. Evidence-based guideline: treatment of convulsive status epilepticus in children and adults: report of the guideline committee of the American Epilepsy Society. Epilepsy Curr. 2016;16(1):48–61.

  45. 45.

    Harris D, Hall C, Lobay K, et al. Canadian Association of Emergency Physicians position statement on acute ischemic stroke. Cjem. 2015;17(2):217–26.

  46. 46.

    Hemphill JC, Adeoye OM, Alexander DN, et al. Clinical performance measures for adults hospitalized with intracerebral hemorrhage: performance measures for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2018;49(7):e243–61.

  47. 47.

    Hofmeijer J, Kappelle LJ, Algra A, et al. Surgical decompression for space-occupying cerebral infarction (the Hemicraniectomy After Middle Cerebral Artery infarction with Life-threatening Edema Trial [HAMLET]): a multicentre, open, randomised trial. Lancet Neurol. 2009;8(4):326–33.

  48. 48.

    Howes D, Gray SH, Brooks SC, et al. Canadian Guidelines for the use of targeted temperature management (therapeutic hypothermia) after cardiac arrest: a joint statement from The Canadian Critical Care Society (CCCS), Canadian Neurocritical Care Society (CNCCS), and the Canadian Critical Care Trials Group (CCCTG). Resuscitation. 2016;98:48–63.

  49. 49.

    Hughes RA, Brassington R, Gunn AA, van Doorn PA. Corticosteroids for Guillain-Barre syndrome. Cochrane Database Syst Rev. 2016;10:CD001446.

  50. 50.

    Hughes RA, Swan AV, van Doorn PA. Intravenous immunoglobulin for Guillain-Barre syndrome. Cochrane Database Syst Rev. 2014;9:CD002063.

  51. 51.

    Hughes RA, Wijdicks EF, Barohn R, et al. Practice parameter: immunotherapy for Guillain–Barre syndrome: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2003;61(6):736–40.

  52. 52.

    Hypothermia after Cardiac Arrest Study Group. Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N Engl J Med. 2002;346(8):549–56.

  53. 53.

    Jauch EC, Saver JL, Adams HP, et al. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2013;44(3):870–947.

  54. 54.

    Jouan Y, Grammatico-Guillon L, Espitalier F, et al. Long-term outcome of severe herpes simplex encephalitis: a population-based observational study. Crit Care. 2015;19:345.

  55. 55.

    Juttler E, Schwab S, Schmiedek P, et al. Decompressive Surgery for the Treatment of Malignant Infarction of the Middle Cerebral Artery (DESTINY): a randomized, controlled trial. Stroke. 2007;38(9):2518–25.

  56. 56.

    Lange MC, Braga GP, Novak EM, et al. Key performance indicators for stroke from the Ministry of Health of Brazil: benchmarking and indicator parameters. Arq Neuropsiquiatr. 2017;75(6):354–8.

  57. 57.

    Lansberg MG, O’Donnell MJ, Khatri P, et al. Antithrombotic and thrombolytic therapy for ischemic stroke: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012;141(2 Suppl):e601S–36S.

  58. 58.

    Leifer D, Bravata DM, Connors JJ 3rd, et al. Metrics for measuring quality of care in comprehensive stroke centers: detailed follow-up to Brain Attack Coalition comprehensive stroke center recommendations: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011;42(3):849–77.

  59. 59.

    Lin TK, Lien LM, Chen WH, Huang SJ, Su CL. A concise guideline for the management of large hemispheric infarction in Taiwan: 2010 update: a guideline from the Taiwan Stroke Society. Acta Neurol Taiwan. 2010;19(4):296–302.

  60. 60.

    Martins SC, Freitas GR, Pontes-Neto OM, et al. Guidelines for acute ischemic stroke treatment: part II: stroke treatment. Arq Neuropsiquiatr. 2012;70(11):885–93.

  61. 61.

    Mauri Llerda JA, Suller Marti A, de la Pena Mayor P, et al. The Spanish Society of Neurology’s official clinical practice guidelines for epilepsy. Special considerations in epilepsy: comorbidities, women of childbearing age, and elderly patients. Neurologia. 2015;30(8):510–7.

  62. 62.

    McGill F, Heyderman RS, Michael BD, et al. The UK joint specialist societies guideline on the diagnosis and management of acute meningitis and meningococcal sepsis in immunocompetent adults. J Infect. 2016;72(4):405–38.

  63. 63.

    McTaggart RA, Ansari SA, Goyal M, et al. Initial hospital management of patients with emergent large vessel occlusion (ELVO): report of the standards and guidelines committee of the Society of NeuroInterventional Surgery. J Neurointerv Surg. 2017;9(3):316–23.

  64. 64.

    Medicaid, C.f.M.a. Venous thromboembolism measure 6 2018. Retrieved September 29, 2019, from https://ecqi.healthit.gov/ecqm/eh/2018/cms108v6.

  65. 65.

    Meierkord H, Boon P, Engelsen B, et al. EFNS guideline on the management of status epilepticus in adults. Eur J Neurol. 2010;17(3):348–55.

  66. 66.

    Michel P, Arnold M, Hungerbuhler HJ, et al. Decompressive craniectomy for space occupying hemispheric and cerebellar ischemic strokes: Swiss recommendations. Int J Stroke. 2009;4(3):218–23.

  67. 67.

    Minematsu K, Toyoda K, Hirano T, et al. Guidelines for the intravenous application of recombinant tissue-type plasminogen activator (alteplase), the second edition, October 2012: a guideline from the Japan Stroke Society. J Stroke Cerebrovasc Dis. 2013;22(5):571–600.

  68. 68.

    Minicucci F, Muscas G, Perucca E, et al. Treatment of status epilepticus in adults: guidelines of the Italian League against Epilepsy. Epilepsia. 2006;47(Suppl 5):9–15.

  69. 69.

    National Institute for Health and Care Excellence, N.N. Tuberculosis: prevention, diagnosis, managment and service organization. London: National Institute for Health and Care Excellence; 2016.

  70. 70.

    Neuorology, A.A.o. Endovascular Treatment and Imaging Measure Bundle. 2016. Retrieved September 29, 2019, from https://www.aan.com/policy-and-guidelines/quality/quality-measures2/quality-measures/stroke-and-vascular-neurology/.

  71. 71.

    Neuorology, A.A.o. Quality measurement set. 2016. https://www.aan.com/siteassets/home-page/policy-and-guidelines/quality/quality-measures/17iemeasureset_pg.pdf. Cited in 1st Nov 2018.

  72. 72.

    Nielsen N, Wetterslev J, Cronberg T, et al. Targeted temperature management at 33 degrees C versus 36 degrees C after cardiac arrest. N Engl J Med. 2013;369(23):2197–206.

  73. 73.

    Norrving B, Bray BD, Asplund K, et al. Cross-national key performance measures of the quality of acute stroke care in Western Europe. Stroke. 2015;46(10):2891–5.

  74. 74.

    Nyquist P, Bautista C, Jichici D, et al. Prophylaxis of venous thrombosis in neurocritical care patients: an evidence-based guideline: a statement for healthcare professionals from the Neurocritical Care Society. Neurocrit Care. 2016;24(1):47–60.

  75. 75.

    O’Brien JJ, Campoli-Richards DM. Acyclovir. An updated review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy. Drugs. 1989;37(3):233–309.

  76. 76.

    Pastores SM, Annane D, Rochwerg B. Guidelines for the diagnosis and management of critical illness-related corticosteroid insufficiency (CIRCI) in Critically Ill Patients (Part II): society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM) 2017. Crit Care Med. 2018;46(1):146–8.

  77. 77.

    Patwa HS, Chaudhry V, Katzberg H, Rae-Grant AD, So YT. Evidence-based guideline: intravenous immunoglobulin in the treatment of neuromuscular disorders: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 2012;78(13):1009–15.

  78. 78.

    Powers WJ, Derdeyn CP, Biller J, et al. 2015 American Heart Association/American Stroke Association focused update of the 2013 guidelines for the early management of patients with acute ischemic stroke regarding endovascular treatment: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2015;46(10):3020–35.

  79. 79.

    Powers WJ, Rabinstein AA, Ackerson T, et al. 2018 guidelines for the early management of patients with acute ischemic stroke: a guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2018;49(3):e46–110.

  80. 80.

    Prasad K, Singh MB, Ryan H. Corticosteroids for managing tuberculous meningitis. Cochrane Database Syst Rev. 2016;4:CD002244.

  81. 81.

    Roberts I, Yates D, Sandercock P, et al. Effect of intravenous corticosteroids on death within 14 days in 10008 adults with clinically significant head injury (MRC CRASH trial): randomised placebo-controlled trial. Lancet. 2004;364(9442):1321–8.

  82. 82.

    Schwartz J, Padmanabhan A, Aqui N, et al. Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the writing committee of the American Society for Apheresis: the seventh special issue. J Clin Apher. 2016;31(3):149–62.

  83. 83.

    Schwartz J, Winters JL, Padmanabhan A, et al. Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Writing Committee of the American Society for Apheresis: the sixth special issue. J Clin Apher. 2013;28(3):145–284.

  84. 84.

    Sejvar JJ, Baughman AL, Wise M, Morgan OW. Population incidence of Guillain–Barre syndrome: a systematic review and meta-analysis. Neuroepidemiology. 2011;36(2):123–33.

  85. 85.

    Skeie GO, Apostolski S, Evoli A, et al. Guidelines for the treatment of autoimmune neuromuscular transmission disorders. Eur J Neurol. 2006;13(7):691–9.

  86. 86.

    Skoldenberg B, Forsgren M, Alestig K, et al. Acyclovir versus vidarabine in herpes simplex encephalitis. Randomised multicentre study in consecutive Swedish patients. Lancet. 1984;2(8405):707–11.

  87. 87.

    Smith EE, Saver JL, Alexander DN, et al. Clinical performance measures for adults hospitalized with acute ischemic stroke: performance measures for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014;45(11):3472–98.

  88. 88.

    Solomon T, Michael BD, Smith PE, et al. Management of suspected viral encephalitis in adults–Association of British Neurologists and British Infection Association National Guidelines. J Infect. 2012;64(4):347–73.

  89. 89.

    Solter VV, Roje-Bedekovic M, Breitenfeld T, et al. Recommendations for the management of medical complications in patients following aneurysmal subarachnoid hemorrhage. Acta Clin Croat. 2014;53(1):113–38.

  90. 90.

    Steiner I, Budka H, Chaudhuri A, et al. Viral meningoencephalitis: a review of diagnostic methods and guidelines for management. Eur J Neurol. 2010;17(8):999-e57.

  91. 91.

    Steiner T, Juvela S, Unterberg A, et al. European Stroke Organization guidelines for the management of intracranial aneurysms and subarachnoid haemorrhage. Cerebrovasc Dis. 2013;35(2):93–112.

  92. 92.

    Suarez JI. Diagnosis and management of subarachnoid hemorrhage. Continuum (Minneap Minn). 2015;21(5 Neurocritical Care):1263–87.

  93. 93.

    Tallarico RT, Pizzi MA, Freeman WD. Investigational drugs for vasospasm after subarachnoid hemorrhage. Expert Opin Investig Drugs. 2018;27(4):313–24.

  94. 94.

    The Joint Commission. Comprehensive stroke certification: standardized performance measures. 2018. https://www.jointcommission.org/performance_measures_for_comprehensive_stroke_centers/. Cited in 1st Nov 2018.

  95. 95.

    The Joint Commission. Measure STK-4: thrombolytic therapy. 2018. https://manual.jointcommission.org/releases/TJC2018A/MIF0129.html. Cited in 1st Nov 2018.

  96. 96.

    Thwaites G, Fisher M, Hemingway C, et al. British Infection Society guidelines for the diagnosis and treatment of tuberculosis of the central nervous system in adults and children. J Infect. 2009;59(3):167–87.

  97. 97.

    Tunkel AR, Glaser CA, Bloch KC, et al. The management of encephalitis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2008;47(3):303–27.

  98. 98.

    Tunkel AR, Hartman BJ, Kaplan SL, et al. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis Offic Publ Infect Dis Soc Am. 2004;39(9):1267–84.

  99. 99.

    Tunkel AR, Hasbun R, Bhimraj A, et al. Infectious Diseases Society of America’s clinical practice guidelines for healthcare-associated ventriculitis and meningitis. Clin Infect Dis. 2017;64:e34–65.

  100. 100.

    Vahedi K, Vicaut E, Mateo J, et al. Sequential-design, multicenter, randomized, controlled trial of early decompressive craniectomy in malignant middle cerebral artery infarction (DECIMAL Trial). Stroke. 2007;38(9):2506–17.

  101. 101.

    van de Beek D, Cabellos C, Dzupova O, et al. ESCMID guideline: diagnosis and treatment of acute bacterial meningitis. Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis. 2016;22(Suppl 3):S37–62.

  102. 102.

    Venketasubramanian N, Pwee KH, Chen CP. Singapore Ministry of Health Clinical practice guidelines workgroup on, S. Transient ischaemic, A. Singapore ministry of health clinical practice guidelines on stroke and transient ischemic attacks. Int J Stroke. 2011;6(3):251–8.

  103. 103.

    Vivancos J, Gilo F, Frutos R, et al. Clinical management guidelines for subarachnoid haemorrhage. Diagnosis and treatment. Neurologia. 2014;29(6):353–70.

  104. 104.

    Whitley RJ, Alford CA, Hirsch MS, et al. Vidarabine versus acyclovir therapy in herpes simplex encephalitis. N Engl J Med. 1986;314(3):144–9.

  105. 105.

    Whitley RJ, Gnann JW Jr. Acyclovir: a decade later. N Engl J Med. 1992;327(11):782–9.

  106. 106.

    Wijdicks EF, Sheth KN, Carter BS, et al. Recommendations for the management of cerebral and cerebellar infarction with swelling: a statement for healthcare professionals from the american heart association/american stroke association. Stroke. 2014;45(4):1222–38.

  107. 107.

    Willison HJ, Jacobs BC, van Doorn PA. Guillain–Barre syndrome. Lancet. 2016;388(10045):717–27.

  108. 108.

    Wong GC, van Diepen S, Ainsworth C, et al. Canadian Cardiovascular Society/Canadian Cardiovascular Critical Care Society/Canadian Association of interventional cardiology position statement on the optimal care of the postarrest patient. Can J Cardiol. 2017;33(1):1–16.

  109. 109.

    Xu AD, Wang YJ, Wang DZ. Chinese stroke therapy expert panel for intravenous recombinant tissue plasminogen, A. consensus statement on the use of intravenous recombinant tissue plasminogen activator to treat acute ischemic stroke by the Chinese Stroke Therapy Expert Panel. CNS Neurosci Ther. 2013;19(8):543–8.

Download references

Funding

The NCS Performance Measure Writing Group phone and in-person meetings were supported financially by the Neurocritical Care Society. No additional funding or support was received by any group member for this work.

Author information

This manuscript complies with all instructions to authors. Authorship requirements for all authors have been met and the final manuscript was approved by all authors. This manuscript has not been published elsewhere and is not under consideration by another journal. The group adhered to ethical guidelines and no IRB approval was needed for the development of this statement.

Correspondence to Sarah Livesay.

Ethics declarations

Conflicts of Interest

Dr. Livesay reports other from Legal/Expert Witness, other from Lombardi Hill/Stroke Challenges, other from Sarah Livesay, LLC, outside the submitted work. Dr. Fried has nothing to disclose. Dr. Gagnon has nothing to disclose. Dr. Karanjia reports other from Legal/expert witness, other from Bard, outside the submitted work. Dr. Lele reports other from LifeCenter Northwest, grants from Aqueduct Critical Care, outside the submitted work. Dr. Moheet has nothing to disclose. Dr. Taccone reports other from Bard, outside the submitted work. Dr. Olm-Shipman has nothing to disclose. Dr. Tirschwell has nothing to disclose. Dr. Wright reports other from Legal/Expert Witness, outside the submitted work. Dr. Hemphill reports other from Legal/Expert Witness, outside the submitted work.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Appendices

Appendix 1

See Table 3.

Table 3 Systematic review search strategy

Appendix 2: Neurocritical Care Performance Measure Set

figurea
figureb
figurec
figured
figuree
figuref
figureg
figureh
figurei
figurej
figurek
figurel
figurem
figuren
figureo
figurep
figureq
figurer
figures
figuret
figureu
figurev
figurew
figurex
figurey
figurez
figureaa
figureab
figureac
figuread
figureae
figureaf
figureag
figureah
figureai
figureaj
figureak
figureal
figuream
figurean
figureao
figureap
figureaq
figurear
figureas
figureat
figureau
figureav
figureaw
figureax
figureay
figureaz
figureba
figurebb
figurebc
figurebd
figurebe
figurebf
figurebg
figurebh
figurebi

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Livesay, S., Fried, H., Gagnon, D. et al. Clinical Performance Measures for Neurocritical Care: A Statement for Healthcare Professionals from the Neurocritical Care Society. Neurocrit Care 32, 5–79 (2020). https://doi.org/10.1007/s12028-019-00846-w

Download citation

Keywords

  • Neurocritical care
  • Performance measures
  • Quality
  • Metrics